SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is currently the focal point of intense community debate, driven by a high-stakes mix of aggressive Bitcoin accumulation strategies and concerns over ongoing equity dilution. Traders are actively clashing over the company's long-term sustainability versus its role as a leveraged proxy for crypto, with sentiment deeply split between those anticipating a major breakout and those bracing for further downside.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is currently trending amid significant market volatility and ongoing debate over the impact of the U.S. Clarity Act, with community discussions polarized between retail investors frustrated by price stagnation and others advocating for long-term accumulation based on anticipated institutional adoption. The sentiment is heavily influenced by macroeconomic pressures, geopolitical tensions, and skepticism regarding the timing of regulatory milestones, leading to a split between those capitulating and those viewing the current price action as a strategic entry point.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors react to a cryptic message from founder Patrick Soon-Shiong about strengthening the balance sheet and global expansion, sparking intense community debate over whether this signals a strategic partnership or potential dilution. While some fear the move could pressure shareholders, bulls remain highly engaged, viewing the announcement and ongoing international regulatory progress as signs of a looming major catalyst that could trigger a significant short squeeze.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space is gaining significant market attention as traders bet on a potential short squeeze, fueled by the stock's tiny float and heightened speculation surrounding an anticipated SpaceX IPO. While retail investors actively discuss the company's hypersonic flight R&D partnerships and potential for sector-wide momentum, skeptics are sounding alarms over recent executive departures and a lack of verified commercial revenue.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC remains at the center of the AI infrastructure conversation as the company navigates capacity constraints and significant insider buying, signaling strong internal conviction in its long-term trajectory. While the semiconductor sector contends with broader tech volatility, the community is actively tracking the company's essential role in supplying advanced nodes to major AI hardware players.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is facing increased selling pressure and a technical correction, as investors grapple with sector-wide volatility and uncertainty surrounding AI demand. The community is actively debating the stock's long-term valuation against the backdrop of broader market instability, geopolitical concerns, and shifting narratives regarding AI infrastructure efficiency.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is experiencing heightened volatility as investors weigh strong earnings and revenue growth against concerns over future guidance and the sector's shift toward optical interconnects. The community remains divided, with some actively buying the dip, citing strong institutional backing and growth potential, while others express frustration over the stock's recent price breakdown.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending due to a significant earnings report that revealed a record order backlog driven by intense global demand for advanced AI chip infrastructure. The community is focused on the company's long-term monopolistic position in EUV lithography and its role as an indispensable gatekeeper for next-generation semiconductor manufacturing.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently drawing intense market attention as traders weigh conflicting signals from ongoing geopolitical tensions in the Middle East against speculation surrounding a potential SpaceX IPO. Community discourse remains highly polarized, with active debate centered on the impact of potential delivery figures, leadership departures, and the stock's valuation relative to its high price-to-earnings multiple.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna is surging as investors pivot to the companys strategic natural gas assets in Italy, which are viewed as a critical supply alternative amidst escalating geopolitical tensions and regional energy infrastructure threats in the Middle East. The stock has captured intense community interest due to a tight float, high cost-to-borrow rates, and mounting anticipation for a potential short squeeze, with active discussions focusing on the significant upside potential of both shares and warrants.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The attachment lists all commercial-stage non-oncoloy focused bios with FDA approvals between 1/1/2018 &amp; 12/31/2023 noting market cap, actual FY25 revenues &amp; gross margin, 5-year analyst consensus &amp; related revenue multiples. 
 
$OCUL is now down 50% its recent high after rejected an enhanced Sanofi offer for more than $16 a share. OCUL FY25 represents Dextenza sales only. The growth is anticipated from Axpaxli that has a Phase 3 reading soon. 
 
$HRMY trades at the lowest multiple of FY26 consensus (but has an imminent patent cliff...offset by multiple late-stage reads). 
 
$ARDX continues to trade at the lowest multiples in any commercial-stage peer group 
 
$XERS hit $10 a share last Halloween &amp; is off 45% since 
 
$APLS appears a head scratcher. 
 
This is not investment advice.

Goldenbluey

Bozo

Mick

Dee Cee

Lenni

Dr. Zebra

Your Friend

Diddysjury

Moon Shot

Phillip

Bill Rader

Steve Gonzalez

Paula

Insert Name Here

Piktoro

John Bowman

Sana

StockTwits Web

Ocular Therapeutix Inc

Harmony Biosciences Holdings Inc

Ardelyx Inc

Xeris Biopharma Holdings Inc

Apellis Pharmaceuticals Inc

The attachment lists all commercial-stage non-oncoloy focused bios with FDA approvals between 1/1/2018 & 12/31/2023 noting market cap, actual FY25 revenues & gross margin, 5-year analyst consensus & related revenue multiples. 
 


 is now down 50% its recent high after rejected an enhanced Sanofi offer for more than $16 a share. OCUL FY25 represents Dextenza sales only. The growth is anticipated from Axpaxli that has a Phase 3 reading soon. 
 


 trades at the lowest multiple of FY26 consensus (but has an imminent patent cliff...offset by multiple late-stage reads). 
 


 continues to trade at the lowest multiples in any commercial-stage peer group 
 


 hit $10 a share last Halloween & is off 45% since 
 


 appears a head scratcher. 
 
This is not investment advice.

iShares Biotechnology ETF

Incyte Corp.

SPDR S&P Biotech ETF

Syndax Pharmaceuticals Inc

NASDAQ Biotechnology

UroGen Pharma Ltd

Iovance Biotherapeutics Inc

Day One Biopharmaceuticals Inc

Night Owl Biotech Research

Seres Therapeutics Inc

@Night_Owl_Biotech 

https://x.com/crypto_biotech/status/2036090954231267601?s=46

👏🏻👏🏻👏🏻😎

ARDX🏅Trading at the LOWEST multiples in its entire commercial-stage non-oncology biotech peer group with best-in-class gross margins 📈for FY2025, rock-solid fundamentals, and a management team that has executed after past miscues. Shoutout to Night_Owl_Biotech👏🏻 pic.twitter.com/Jkjv2isUEV

X (Formerly Twitter)

BioPharm_the_Magnificent on X (formerly Twitter): "$ARDX🏅Trading at the LOWEST multiples in its entire commercial-stage non-oncology biotech peer group with best-in-class gross margins 📈for FY2025, rock-solid fundamentals, and a management team that ha...